ALBUQUERQUE NEUROSCIENCE
  • Home
  • Participate in a Study
  • Our Experience
  • Resources
  • Contact Us
  • Sponsors & CRO's
REGISTER NOW

Current Studies

A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)
  • For participants ages 18 to 45 experiencing Postpartum Depression.
  • Gave birth within the last 6 months.
  • Depression symptoms began at some point between the third trimester and 4 weeks after delivery.
  • Willing to consider alternatives to breastfeeding while taking study medication (3 weeks).

INTERVIEWS IN ADULTS WITH MAJOR DEPRESSIVE DISORDER AND SLEEP DISTURBANCE
  • Ages 18 to 74
  • Currently taking a medication for depression
  • Currently experiencing depression with sleep disturbance
  • Have access to a PC computer and internet and able to complete a 90 minute interview in a private setting

This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia
  • For participants ages 18 to 50
  • Diagnosis of schizophrenia.
  • Symptoms and treatments have been generally stable for the last 3 months.
  • Have a study partner who can participate in the study also.

Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation (Vibrant)
  • For participants ages 22 and older
  • On average have between 1 and 3 spontaneous (with out laxative) bowel movements a week.

​
GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease
  • For participants ages 55 to 80
  • Have Mild to Moderate Alzheimer's Disease
  • Have a Study Partner or Caregiver who can attend study visit

    Contact us to find out more about OUR studies.

Submit
Albuquerque Neuroscience, Inc.
101 Hospital Loop NE, Suite 209
Albuquerque, New Mexico 87109
Phone: (505) 848-3773
Fax: (505) 848-3741
E-mail: albneuro@albneuro.com